SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001725160-21-000183
Filing Date
2021-08-12
Accepted
2021-08-12 07:53:46
Documents
73
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zntl-20210630.htm   iXBRL 10-Q 1975399
2 EX-31.1 zentalis10-qq22021ex311.htm EX-31.1 10418
3 EX-31.2 zentalis10-qq22021ex312.htm EX-31.2 10624
4 EX-32.1 zentalis10-qq22021ex321.htm EX-32.1 5292
5 EX-32.2 zentalis10-qq22021ex322.htm EX-32.2 5687
  Complete submission text file 0001725160-21-000183.txt   7291882

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20210630.xsd EX-101.SCH 41888
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zntl-20210630_cal.xml EX-101.CAL 66318
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20210630_def.xml EX-101.DEF 231463
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20210630_lab.xml EX-101.LAB 510849
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20210630_pre.xml EX-101.PRE 381064
11 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20210630_htm.xml XML 1101548
Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39263 | Film No.: 211165523
SIC: 2834 Pharmaceutical Preparations